Long-term (+52 weeks) randomized controlled trial of anti-depressants shows that they're safe and effective
One-OffSağlık ve Tıp3yManifold MarketsKYC yokDoğrulanmış sonuçlanma verisiOrta düzey kalibreGüncel topluluk tahminiEvet 68.8%
Tahminciler
7
Soru türü
binary
Yöntem
Play-money forecasting platform
Kaynak türü
Tahmin
Piyasa verileri
4 saat önce güncellendi
Guncelligini yitirmis6 Mar 25 19:37 UTC14 Mar 30 10:59 UTC
Trendler
Kurallar
Randomized placebo-controlled studies of antidepressants are under 52 weeks, yet the median use of antidepressants is 5 years.
- This market predicts whether the next eligible trial of antidepressants shows that they are safe and effective over 52 weeks duration
- Definitions:
- eligible trial - placebo-controlled randomized controlled trial over 52 weeks that measures both efficacy and safety
- effective - beats placebo control
- safe - risks and side effects are not found to be worse than currently known
